Abstract
The study aimed to assess the strengths and weaknesses, opportunities and threats influencing the achievement of prevention of mother-to-child transmission of hepatitis B virus. It also sought to suggest recommendations to improve the current prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria. A critical appraisal of the prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria was conducted. The WHO health system framework was used to assess the prevention of mother-to-child transmission of hepatitis B virus system. Considering the recent call by the World Health Organization to eliminate hepatitis and the existence of a robust prevention of mother-to-child transmission of human immunodeficiency virus health system, the prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria is riddled with numerous challenges. These range from a health worker crisis, poor leadership and governance, inadequate health information, medicines, vaccines and technologies and poor service delivery. Urgent action in the Nigerian prevention of mother-to-child transmission of hepatitis B virus health system is required if Nigeria is to achieve its goal of eliminating hepatitis by 2021. Key words: Mother-to-child-transmission, hepatitis B Virus, health system, Nigeria.
Highlights
Hepatitis B Virus (HBV) constitutes a huge public health burden worldwide (WHO, 2012)
The aim of this study was to conduct a critical appraisal of the PMTCT-HBV health system in Nigeria with a view to assessing its strengths and weaknesses, opportunities and threats influencing the achievement of PMTCT-HBV
Service delivery In Nigeria, health services are delivered through tertiary, secondary and primary health facilities run by the Federal, State, and Local government tiers of government respectively (Okonofua et al, 2011; Federal Ministry of Health (FMoH), 2016a)
Summary
Hepatitis B Virus (HBV) constitutes a huge public health burden worldwide (WHO, 2012) It is the commonest cause of Chronic Liver Disease (CLD) in Nigeria (Musa et al, 2015). HBV is vaccinepreventable yet Nigeria is hyper-endemic (14%) for HBV with about 24 million infected people, majority of who are children and young adults (Musa et al, 2015; Forbi et al, 2010). This estimate places Nigeria as one of the most HBV affected countries in Africa (Ott et al, 2012).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
